FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894041796> ?p ?o ?g. }

• W2894041796 endingPage "354" @default.
• W2894041796 startingPage "345" @default.
• W2894041796 abstract "Immunomodulatory antibodies blocking interactions of coinhibitory receptors to their ligands such as CTLA‐4, PD1 and PD‐L1 on immune cells have shown impressive therapeutic efficacy in clinical studies. The therapeutic effect of these antibodies is mainly mediated by reactivating antitumor T cell immune responses. Detailed analysis of anti‐CTLA4 antibody therapy revealed that an optimal therapeutic efficacy also requires binding to Fc receptors for IgG, FcγR, mediating depletion of intratumoral regulatory T cells. Here, we investigated the role of Fc binding in anti‐PD‐L1 antibody therapy in the MC38 C57BL/6 and CT26 BALB/c colon adenocarcinoma tumor models. In the MC38 tumor model, all IgG subclasses anti‐PD‐L1 showed similar therapeutic efficacy when compared to each other in either wild‐type mice or in mice deficient for all FcγR. In contrast, in the CT26 tumor model, anti‐PD‐L1 mIgG2a, the IgG subclass with the highest affinity for activating FcγR, showed stronger therapeutic efficacy than other IgG subclasses. This was associated with a reduction of a myeloid cell subset with high expression of PD‐L1 in the tumor microenvironment. This subclass preference for mIgG2a was lost in C57BL/6 × BALB/c F1 mice, indicating that the genetic background of the host may determine the additional clinical benefit of the high affinity antibody subclasses. Based on these data, we conclude that FcγR are not crucial for anti‐PD‐L1 antibody therapy but might play a role in some tumor models." @default.
• W2894041796 created "2018-10-05" @default.
• W2894041796 creator A5001749725 @default.
• W2894041796 creator A5001994531 @default.
• W2894041796 creator A5011904912 @default.
• W2894041796 creator A5014075850 @default.
• W2894041796 creator A5019941146 @default.
• W2894041796 creator A5021665742 @default.
• W2894041796 creator A5025621864 @default.
• W2894041796 creator A5028047183 @default.
• W2894041796 creator A5035490415 @default.
• W2894041796 creator A5046864809 @default.
• W2894041796 creator A5061083695 @default.
• W2894041796 creator A5064962683 @default.
• W2894041796 creator A5065156309 @default.
• W2894041796 creator A5068769338 @default.
• W2894041796 creator A5090318866 @default.
• W2894041796 date "2018-11-12" @default.
• W2894041796 modified "2023-09-26" @default.
• W2894041796 title "FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model" @default.
• W2894041796 cites W1529809181 @default.
• W2894041796 cites W1820495241 @default.
• W2894041796 cites W1862569453 @default.
• W2894041796 cites W1950618346 @default.
• W2894041796 cites W1971208896 @default.
• W2894041796 cites W1977315768 @default.
• W2894041796 cites W1979401452 @default.
• W2894041796 cites W2030632688 @default.
• W2894041796 cites W2049488114 @default.
• W2894041796 cites W2071875829 @default.
• W2894041796 cites W2101581360 @default.
• W2894041796 cites W2104088439 @default.
• W2894041796 cites W2112123471 @default.
• W2894041796 cites W2121080857 @default.
• W2894041796 cites W2124427232 @default.
• W2894041796 cites W2153218957 @default.
• W2894041796 cites W2155074186 @default.
• W2894041796 cites W2170149792 @default.
• W2894041796 cites W2171977041 @default.
• W2894041796 cites W2285436607 @default.
• W2894041796 cites W2289712604 @default.
• W2894041796 cites W2293531514 @default.
• W2894041796 cites W2346775047 @default.
• W2894041796 cites W2414977199 @default.
• W2894041796 cites W2510679674 @default.
• W2894041796 cites W2510686645 @default.
• W2894041796 cites W2559024717 @default.
• W2894041796 cites W2559804019 @default.
• W2894041796 cites W2560525946 @default.
• W2894041796 cites W2567564314 @default.
• W2894041796 cites W2589277622 @default.
• W2894041796 cites W2590023130 @default.
• W2894041796 cites W2610126086 @default.
• W2894041796 cites W2612649234 @default.
• W2894041796 cites W2745624257 @default.
• W2894041796 cites W2753065806 @default.
• W2894041796 cites W2774484554 @default.
• W2894041796 cites W2783234388 @default.
• W2894041796 cites W2791935577 @default.
• W2894041796 doi "https://doi.org/10.1002/ijc.31899" @default.
• W2894041796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30259976" @default.
• W2894041796 hasPublicationYear "2018" @default.
• W2894041796 type Work @default.
• W2894041796 sameAs 2894041796 @default.
• W2894041796 citedByCount "12" @default.
• W2894041796 countsByYear W28940417962019 @default.
• W2894041796 countsByYear W28940417962020 @default.
• W2894041796 countsByYear W28940417962021 @default.
• W2894041796 countsByYear W28940417962022 @default.
• W2894041796 countsByYear W28940417962023 @default.
• W2894041796 crossrefType "journal-article" @default.
• W2894041796 hasAuthorship W2894041796A5001749725 @default.
• W2894041796 hasAuthorship W2894041796A5001994531 @default.
• W2894041796 hasAuthorship W2894041796A5011904912 @default.
• W2894041796 hasAuthorship W2894041796A5014075850 @default.
• W2894041796 hasAuthorship W2894041796A5019941146 @default.
• W2894041796 hasAuthorship W2894041796A5021665742 @default.
• W2894041796 hasAuthorship W2894041796A5025621864 @default.
• W2894041796 hasAuthorship W2894041796A5028047183 @default.
• W2894041796 hasAuthorship W2894041796A5035490415 @default.
• W2894041796 hasAuthorship W2894041796A5046864809 @default.
• W2894041796 hasAuthorship W2894041796A5061083695 @default.
• W2894041796 hasAuthorship W2894041796A5064962683 @default.
• W2894041796 hasAuthorship W2894041796A5065156309 @default.
• W2894041796 hasAuthorship W2894041796A5068769338 @default.
• W2894041796 hasAuthorship W2894041796A5090318866 @default.
• W2894041796 hasBestOaLocation W28940417961 @default.
• W2894041796 hasConcept C121608353 @default.
• W2894041796 hasConcept C126322002 @default.
• W2894041796 hasConcept C159654299 @default.
• W2894041796 hasConcept C170493617 @default.
• W2894041796 hasConcept C203014093 @default.
• W2894041796 hasConcept C2776107976 @default.
• W2894041796 hasConcept C2776194381 @default.
• W2894041796 hasConcept C2777701055 @default.
• W2894041796 hasConcept C2780674031 @default.
• W2894041796 hasConcept C45121317 @default.
• W2894041796 hasConcept C502942594 @default.

• next